MedTrace Logo

Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule

NCT02161276 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2014-09-11

No results posted yet for this study

Summary

Treatment of diabetes mellitus with Traditional Chinese Medicine has a long history.

aim： --establish the optimal dosage of traditional Chinese medicine Tang Ning Tongluo Capsule to treat type II diabetes mellitus.

---Preliminary evaluate the clinical efficacy and safety of Tangning Tongluo Capsule in the treatment of type II diabetes

Conditions

  • Accidental Exposure While Preparing Drug for Administration

Interventions

DRUG

TNTL capsule

Patients were asked to taken drugs 3 times a day, with each time 3 grains

DRUG

Placebo

Patients were asked to taken drugs 3 times a day, with each time 3 grains

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    collaborator OTHER

  • Guizhou Bailing Group Pharmaceutical Co Ltd

    lead INDUSTRY

Principal Investigators

  • XY Xin, Dr. · ICMJE

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-08-31
Completion
2014-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02161276 on ClinicalTrials.gov